Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: A cross-sectional study on adult male population

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Savastano, Silvia ^a   Tarantino, Giovanni ^a,b   D'Esposito, Vittoria ^a   Passaretti, Federica ^a   Cabaro, Serena ^a   Liotti, Antonietta ^a   Liguoro, Domenico ^a   Perruolo, Giuseppe ^a   Ariemma, Fabiana ^a   Finelli, Carmine ^c   Beguinot, Francesco ^a   Formisano, Pietro ^a   Valentino, Rossella ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Cancer Research Center of Mercogliano   (Italy)

^c Stella Maris Mediterraneum Foundation   (Italy)

Author keywords

Bisphenol A; Endocrine disruptors; Metabolic Syndrome; Obesity; Visceral adiposity

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; GLUCOSE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; BENZHYDRYL DERIVATIVE; BIOLOGICAL MARKER; PHENOL DERIVATIVE;

ADULT; ARTICLE; CAUCASIAN; CHRONIC INFLAMMATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; GLUCOSE HOMEOSTASIS; HUMAN; IMPAIRED FASTING GLUCOSE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PREDICTION; PROTEIN BLOOD LEVEL; RISK FACTOR; VISCERAL OBESITY; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; BLOOD; INFLAMMATION; METABOLIC SYNDROME X; REGRESSION ANALYSIS;

ADULT; BENZHYDRYL COMPOUNDS; BIOMARKERS; CROSS-SECTIONAL STUDIES; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; PHENOLS; REGRESSION ANALYSIS; WAIST CIRCUMFERENCE;

EID: 84930207049     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0532-y     Document Type: Article

References (32)

1. Lubrano C, Genovesi G, Specchia P, Costantini D, Mariani S, Petrangeli E et al (2013) Obesity and metabolic comorbidities: environmental diseases? Oxid Med Cell Longev 2013:640673. doi: 10.1155/2013/640673
2. LaKind JS, Goodman M, Naiman DQ (2012) Use of NHANES data to link chemical exposures to chronic diseases: a cautionary tale. PLoS One 7:e51086
3. Rubin BS (2011) Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 127:27-34
4. Vom Saal FS, Nagel SC, Coe BL, Angle BM, Taylor JA (2012) The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cell Endocrinol 354:74-84
5. Xiaoqian G, Hong-Sheng W (2014) Impact of bisphenol A on the cardiovascular system - epidemiological and experimental evidence and molecular mechanisms. Int J Environ Res Public Health 11:8399-8413
6. Müllerová D, Kopecky J (2007) White adipose tissue: storage and effector site for environmental pollutants. Physiol Res 56:375-381
7. Welshons WV, Nagel SC, vom Saal FS (2006) Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147:S56-S69
8. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV (2007) Human exposure to bisphenol A (BPA). Reprod Toxicol 24:139-177
9. Rochester JR (2013) Bisphenol A and human health: a review of the literature. Reprod Toxicol 42:132-155
10. Rezg R, El-Fazaa S, Gharbi N, Mornagui B (2014) Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives. Environ Int 64:83-90
11. Shankar A, Teppala S (2011) Relationship between urinary bisphenol A levels and diabetes mellitus. J Clin Endocrinol Metab 96:3822-3826
12. Teppala S, Madhavan S, Shankar A (2012) Bisphenol A and metabolic syndrome: results from NHANES. Int J Endocrinol 2012:598180
13. Carwile JL, Michels KB (2011) Urinary bisphenol A and obesity: NHANES 2003-2006. Environ Res 111:825-830
14. Silver MK, O'Neill MS, Sowers MR, Park SK (2011) Urinary bisphenol A and type-2 diabetes in U.S. adults: data from NHANES 2003-2008. PLoS One 6:e26868
15. Wang T, Li M, Chen B, Xu M, Xu Y, Huang Y et al (2012) Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab 97:E223-E227
16. Vandenberg LN, Chahoud I, Padmanabhan V, Paumgartten FJ, Schoenfelder G (2010) Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environ Health Perspect 118:1051-1054
17. Vandenberg LN, Ehrlich S, Belcher SM, Ben-Jonathan N, Dolinoy DC, Hugo ER et al (2013) Low dose effects of bisphenol A. An integrated review of in vitro, laboratory animal, and epidemiology studies. Endocr Disrupt 1(1):e25078
18. Takeuchi T, Tsutsumi O, Ikezuki Y, Kamei Y, Osuga Y, Fujiwara T et al (2006) Elevated serum bisphenol A levels under hyperandrogenic conditions may be caused by decreased UDP-glucuronosyltransferase activity. Endocr J 54:485-491
19. Kinch CD, Ibhazehiebo K, Jeong JH, Habibi HR, Kurrasch DM (2015) Low-dose exposure to bisphenol A and replacement bisphenol S induces precocious hypothalamic neurogenesis in embryonic zebrafish. Proc Natl Acad Sci USA 112:1475-1480. doi: 10.1073/pnas.1417731112
20. Liu J, Yu P, Qian W, Li Y, Zhao J, Huan F et al (2013) Perinatal bisphenol A exposure and adult glucose homeostasis: identifying critical windows of exposure. PLoS One 8(5):e64143. doi: 10.1371/journal.pone.0064143
21. Alonso-Magdalena P, Vieira E, Soriano S, Menes L, Burks D, Quesada I et al (2010) Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ Health Perspect 118:1243-1250. doi: 10.1289/ehp.1001993
22. Mielke H, Gundert-Remy U (2009) Bisphenol A levels in blood depend on age and exposure. Toxicol Lett 190:32-40
23. Ohkuma H, Abe K, Ito M, Kokado A, Kambegawa A, Maeda M (2002) Development of a highly sensitive enzyme-linked immunosorbent assay for bisphenol A in serum. Analyst 127:93-97
24. Dekant W, Völkel W (2008) Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol 228:114-134
25. Völkel W, Colnot T, Csanády GA, Filser JG, Dekant W (2002) Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem Res Toxicol 15:1281-1287
26. Rodríguez-Ramírez G, Reyes-Romero MA (2013) Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol 2013:678159. doi: 10.1155/2013/678159
27. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G et al (1998) Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47:1643-1649
28. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB et al (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63
29. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) American Heart Association; National Heart, Lung, and Blood Institute; Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752
30. Rousseeuw PJ, Leroy AM (1987) Robust regression and outlier detection. Wiley-Interscience, John Wiley and Sons, New York. ISBN 0-471-85233-3
31. Valentino R, D'Esposito V, Passaretti F, Liotti A, Cabaro S, Longo M et al (2013) Bisphenol-A impairs insulin action and up-regulates inflammatory pathways in human subcutaneous adipocytes and 3T3-L1 cells. PLoS One 8:e82099
32. Tarantino G, Valentino R, Di Somma C, D'Esposito V, Passaretti F, Pizza G et al (2013) Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis. Clin Endocrinol (Oxf) 78:447-453